LQDA

Liquidia Corp

A biopharmaceutical company that makes YUTREPIA, an inhaled powder that treats pulmonary arterial hypertension, a rare disease of high blood pressure in the lungs. It grew out of work by chemist Joseph DeSimone at the University of North Carolina, who invented a PRINT technology that molds drug particles into precise sizes and shapes, an idea borrowed from how semiconductors are made. The company, based in Morrisville, North Carolina, still builds on that particle-molding method today.

CUSIP: 53635D202HealthcareUS1 holder

Ownership Activity Financials Filings

LQDA

LQDA

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Other Events

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Regulation FD Disclosure

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement